bioAffinity Technologies prices $4M private placement offering

bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) has entered into a securities purchase agreement with an institutional investor for a private placement offering expected to raise approximately $4.0 million in gross proceeds, before placement agent fees and other expenses.

The company will sell 8,462,027 shares of common stock, or pre-funded warrants in lieu thereof, along with two warrants to purchase up to an aggregate of 16,924,054 shares of common stock. The combined effective offering price per share of common stock and accompanying warrants is $0.4727. The pre-funded warrants carry an exercise price of $0.007 per share, while the accompanying warrants have an exercise price of $0.4727 per share.

The warrants will be exercisable following stockholder approval and will expire five years from the date of issuance. WallachBeth Capital LLC is acting as the sole placement agent for the transaction.

The offering is expected to close on or about August 14, 2026, subject to customary closing conditions. The securities are being offered under Section 4(a)(2) of the Securities Act of 1933 and have not been registered under federal or state securities laws. The company has agreed to provide customary registration rights for shares underlying the warrants.

You May Also Be Interested In

• bioAffinity Technologies prices $4M private placement on Nasdaq
• SEALSQ reports 120% revenue growth, signs key quantum deals
• Bed Bath & Beyond names Jill Windrum as CAO and deputy CFO